HKMF

Program

Time 14 May 2022 (Saturday)
12:30-13:30
Boehringer Ingelheim Lunch Symposium
Chairpersons: Prof King-Loong Cheung and Prof David Siu
Fighting heart failure: what tactics and weapons do we have now?
– Prof Andrew Coats (Australia)
13:30-13:40
Welcoming and Opening Remarks
Prof Chak-Sing Lau, Department Chairperson, Department of Medicine, School of Clinical Medicine, The University of Hong Kong
Dr Tony Ko, Chief Executive, Hospital Authority
13:40-14:10
David Todd Distinguished Lecture
Chairperson: Prof Chak-Sing Lau
Mathematical modelling in medicine: case of COVID-19 – Prof Gabriel Leung
14:10-15:25
Updates and Advances in Management of Cardiac Diseases
Chairpersons: Dr Jo Jo Hai and Dr Kai-Hang Yiu
14:10-14:35
Underusage of combination therapy for treating hypertension from the start: does it reflect therapeutic inertia?
– Prof Claudio Borghi (Italy)
14:35-15:00
Management of valvular heart disease – the new spectrum
– Dr Simon Lam
15:00-15:25
Heart failure with preserved ejection fraction – challenges in diagnosis and management
– Dr Jo Jo Hai
15:25-15:45
Break Time
15:45-16:15
Richard Yu Lecture
Chairperson: Prof Richard Yu
Who’s afraid of the big bad wolf? – Prof Chak-Sing Lau
16:15-17:05
Balance in Immune Dysregulation
Chairpersons: Dr Philip Li and Dr Helen Tsang
16:15-16:40
Polymyalgia rheumatica (PMR) – a rheumatic disorder in elderly
– Dr Carmen Ho
16:40-17:05
Lessons from primary immunodeficiencies: caution with biologic therapies
– Dr Philip Li
17:05-18:20
Frontiers in Respiratory Medicine
Chairpersons: Dr Bing Lam and Dr David Lam
17:05-17:30
Continuous positive airway pressure therapy for obstructive sleep apnea:  myths and truths
– Dr Macy Lui
17:30-17:55
Are we diagnosing all types of PF-ILD?
– Prof Luca Richeldi (Italy)
17:55-18:20
Lung cancer – a journey from early detection through diagnosis to management
– Dr David Lam
18:20-18:45
Optimal Care and Treatment of Hepatocellular Carcinoma Patients
Chairperson: Dr Roland Leung
18:20-18:45
One two three in advanced liver cancer
– Dr Thomas Yau
Time 15 May 2022 (Sunday)
09:00-10:00
Clinical Pearls in Medicine
Chairpersons: Dr Patrick Chiu and Dr Anthony Tam
Interactive Workshop for Clinical Practices
Chairpersons: Dr Jacqueline Yuen and Mr Kenneth Yip
09:00-09:30
Interpreting CT coronary angiogram: what you need to know
– Dr Frankie Tam
Prevention of colorectal cancer development
– Dr Michael Cheung & Ms Shetaal Kaur
09:30-10:00
Wiser use of antibiotics
– Dr Pak-Leung Ho
Geriatrics front-door service in QMH
– Dr Yat-Fung Shea & Ms Hoi-Sze She
10:00-11:15
Latest Progress in the Management of Important Gastrointestinal and Liver Diseases
Chairpersons: Dr Michael Cheung and Dr Michael Ko
10:00-10:25
GERD management and appropriate PPI use
– Prof Michael Vaezi (United States)
10:25-10:50
Metabolic-associated fatty liver disease: redefinition and reinterpretation
– Prof Wai-Kay Seto
10:50-11:15
New treatment options for inflammatory bowel disease
– Prof Wai-Keung Leung
11:15-11:35
Break Time
11:35-12:25
Advances in the Management of Thromboembolism and B-cell Lymphomas
Chairpersons: Prof Raymond Liang and Dr Harry Gill
11:35-12:00
Updates on the diagnosis and management of B-cell lymphomas
– Dr Thomas Chan
12:00-12:25
Updates on the management of venous thromboembolism
– Prof Eric Tse
12:25-13:25
Amgen Lunch Symposium
Chairpersons: Dr David Lui and Dr Tai-Pang Ip
Treatment sequence in osteoporosis management: the timing of switching among therapies
– Prof Serge Ferrari (Switzerland)
13:25-14:40
Novel Therapeutics for Complications of Diabetes and Graves’ Disease
Chairpersons: Prof Kathryn Tan and Dr Paul Lee
13:25-13:50
Targeting inflammation and fibrosis in diabetic kidney disease
– Dr Elif Ekinci (Australia)
13:50-14:15
Overcoming the injection barrier to beat the disease process: breakthrough for GLP-1 agonist treatment in T2D
– Prof Michael Lean (United Kingdom)
14:15-14:40
Therapeutic advances in Graves’ orbitopathy: to combine, repurpose, and innovate
– Dr Alan Lee
14:40-15:55
Optimising Patient Care and Outcomes in Chronic Kidney Disease
Chairpersons: Dr Anthony Chan and Dr Desmond Yap
14:40-15:05
SGLT2-inhibitors for DKD and non-diabetic kidney disease
– Prof Sydney Tang
15:05-15:30
Rethink hyperkalemia in managing cardiorenal syndrome – what are the new approaches?
– Dr Andrew Frankel (United Kingdom)
15:30-15:55
Dialysis – long-term complications and outcomes
– Prof Wai-Kei Lo
15:55-16:15
Break Time
16:15-17:30
Clinical Excellency for Important Neurological Disorders
Chairpersons: Dr Koon-Ho Chan and Dr Gary Lau
16:15-16:40
Refractory epilepsy – many stories to tell
– Dr Richard Chang
16:40-17:05
Updates on the management of myasthenia gravis
– Dr Jacky Lee
17:05-17:30
Migraine prevention: real world experience with anti-CGRPs
– Dr Patricia Pozo-Rosich (Spain)
17:30-18:20
Challenges of the COVID-19 Pandemic
Chairpersons: Prof Mary Ip and Dr Yu-Cho Woo
17:30-17:55
COVID-19 vaccine immunogenicity and implications
– Prof David Hui
17:55-18:20
COVID-19 booster vaccine effectiveness and antiviral treatment
– Prof Ivan Hung
18:20-18:25
Closing Remarks
Dr Koon-Ho Chan, Chairman, Organising Committee, 26th HKMF

Last updated: 11 May 2022